Skip to Main Content

Paper Details

Strategies to inhibit FGFR4 V550L-driven rhabdomyosarcoma.
Br J Cancer
2
2022
Author NameAffiliation
Sigve NakkenInstitute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital
Sigve NakkenUniversity of Oslo
  • 1 - 2

Datasets

Release 1.2